Published: 2020-12-25

Prevalence of renal failure patients with three-weekly standardized dialysis session at university teaching hospital of Butare

Leonard Ndayisenga, Charles Nsanzabera, Eugene Hitimana


Background: Dialysis is a treatment of choice to alleviate severe complications of end-stage renal disease. Renal failure is the most prevalent worldwide among diabetic, hypertensive, and where infective diseases are frequent. The study aimed to assess the prevalence of patients having three standard dialysis sessions weekly at University Teaching hospital of Butare dialysis centre from June 2013 to June 2014.

Methods: A descriptive cross-sectional study used routine hospital data from university teaching hospital of Butare dialysis unit and its size were 110 patients who fulfilled the study inclusion criteria. Secondary data were collected using a checklist with different variables like age, sex, profession, health insurances, acute renal failure, chronic renal failure, diabetes mellitus, hypertension, glomerular disease sepsis, severe dehydration, frequency of dialysis per week and outcomes like renal recovery, death, stopping treatment and being referred. Data were analysed using SPSS software.

Results: The findings showed that 40.9% of patients received three or above dialysis sessions per week and 59.1% of patients received less than three sessions per week.

Conclusions: The study concluded on inadequacy dialysis treatment and recommended further studies to explore more about this inadequacy.


Dialysis, Renal failure, University Teaching Hospital of Butare

Full Text:




McPhee PM. Current Medical Diagnosis and Treatment.: McGrew Hills Professional; 2008.

Andrew L, Josef C. K/DOQI Clinical Practice Guidelines For Chronic Kidney Disease: Evaluation, Classification and Stratification. New York, NY 10016: National Kidney Foundation; 2002.

Hricik MR, Sedor J. Technical Aspects of Peritoneal Dialysis. Nephrology Secrets 2nd Edition: Elsevier India; 2012.

Judith G, Stephan S. Emergency Medicine: A Comprehensive Study Guide. Sixth Edition. North Carolina: Copyright 2004. McGraw Hill Companies, Inc.; 2004.

Bocheng J, Scott T, Nicole H, Romita M, Saraladevi N, Uptal P. The Epidemiology of chronic Kidney disease in Sub-Saharan Africa: a systematic review and meta-analysis. Vol 2. 2014.

Ntarindwa. First kidney diseases symposium in Rwanda. Kigali 2014.

Stankuvien Z, Kuzminskis B. Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuanianduring 1998-2005. Medicina(Kaunas) 46. 2010:516-21.

Malekmakan HP. Dialysis adequacy and Kidney Disease Outcomes Quality Initiative goals achievement in an Iranian hemodialysis population. Iran J Kidney Dis 4. 2010:39-4.

Nzambaza. Hemodialysis Unit at BUTH. Butare 2014.

Rwanda Biomedical Center. State Minister for Health opens kidney disease symposium. 2014.

Lin. Nephrology in China: A great mission and momentous Challenge. Kidney Int Suppl. 2003:63: 108-10.

Sitprija. Nephrology in south East Asia: Facts and Concepts. Kidney Int Suppl 63. 2003:128-30.

Chauhan R, Mendonca S. Adequacy of twice-weekly haemodialysis in end stage renal disease patients at a tertiary care dialysis centre. Indian J Nephrol. Dec 2015;25(6):329-33.

Jose AM, Richard JF, Weinhandl E, Sheru K, McCullough P, Komenda P. Intensive Hemodialysis and Treatment Complications and Tolerability. AJKD. 2006.

Amit XG, Rita SS, Paul E, et al. Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Kidney International. 2017:91 (3): 746-754.

Belding J, Suhail C. Why thrice weekly dialysis? Washington: University of Washington and the Northwest Kidney Centers, Seattle, U.S.A.. Hemodialysis International. 2004:8:188-192.

Amini A, Masoudkabir. Hemodialysis adequacy and treatment in Iranian patients: A ntional Multicenter study. Iran I Kidney Dis. 2011:5 103-9.

Shaw SW. Chapter 7 Adequacy of Hemodialysis in UK Adult patients in 2010: National and Centre-Specific Analyses. Nephron Clin Pract. 2012.

Aminu KB, Adeera L, Meaghan L, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. British medical journal. October 2019:15873.

Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clinical nephrology. November 2010:74.

Valerie AL, Brendan S, David CHH, Roberto PF. Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey. Kidney International Supplements. 2020;10:10-18.

Nyandwi J. The cost of dialysis is a big challenge in Burundi. Bujumbura 2014.

Sujha S, Robai G, Joseph K, Gladwell G, Patrick E, Elijah O. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors. January 2018;13(1):e0190113.

Mary C, John C. Proposed treatment program for acute renal failure (ARF) in the United Republic of Tanzania as a model for sub-Saharan Africa. Journal of hospital marketing and public relations. 2007;18(1):81-88.

Okunola O, Ayodele O, Akinsola A. Kidney diseases in Africa: aetiological considerations, peculiarities and burden. African journal of medicine and medical sciences. 2012;41(2):119-133.

Hasan AA, Sarra E. Peritoneal dialysis in Africa. Peritoneal dialysis international. 2010;30(1):23-28.

Barsoum RS. Burden of end-stage kidney disease: North Africa. Clinical nephrology. 2016(13):14-17.